Abstract | STUDY OBJECTIVES: DESIGN: Prospective cohort study. SETTING: A facility that makes an epoxy resin product requiring HHPA for its manufacture. PARTICIPANTS: Sixty-six individuals newly hired at a facility that makes an epoxy resin product requiring HHPA for its manufacture. INTERVENTION: Employees who wished to use respiratory protective equipment could choose from three types of masks: dust mask, half-face organic vapor respirator, or full-face organic vapor respirator. MEASUREMENTS: Workers were evaluated annually for development of positive antibody to HHPA and occupational, immunologic respiratory disease, including occupational asthma. RESULTS: With use of respiratory protective equipment, the rate of developing an occupational immunologic respiratory disease was reduced from approximately 10 to 2% per year. Occupational asthma developed in only three individuals, and they were all in the higher exposure category. Statistically, one respirator was not superior to the others. CONCLUSION: Respiratory protective equipment can reduce the incidence of occupational immunologic respiratory disease, including occupational asthma, in employees exposed to HHPA.
|
Authors | Leslie C Grammer, Kathleen E Harris, Paul R Yarnold |
Journal | Chest
(Chest)
Vol. 121
Issue 4
Pg. 1317-22
(Apr 2002)
ISSN: 0012-3692 [Print] United States |
PMID | 11948068
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Air Pollutants, Occupational
- Bronchoconstrictor Agents
- Epoxy Resins
- Immunoglobulin G
- Phthalic Anhydrides
- araldite
- Immunoglobulin E
|
Topics |
- Adult
- Air Pollutants, Occupational
(adverse effects, immunology)
- Antibody Formation
(immunology)
- Asthma
(immunology, prevention & control)
- Bronchoconstrictor Agents
(adverse effects, immunology)
- Environmental Monitoring
- Epoxy Resins
(adverse effects)
- Female
- Humans
- Immunoglobulin E
(blood)
- Immunoglobulin G
(blood)
- Male
- Middle Aged
- Occupational Diseases
(immunology, prevention & control)
- Phthalic Anhydrides
(adverse effects, immunology)
- Respiratory Protective Devices
- Risk Factors
|